IRCT2015102114086N6CompletedPhase 2
The effect of tablet containing Boswellia serrata extract and Mellisa officinalis extract on memory of the elderly
Barij Essence CO.0 sites80 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 60 years to 75 years (—)
- Sex
- All
Inclusion Criteria
- •Informed consent and willingness to participate in the study; Age 60 to 75 years; Full consciousness.
- •Exclusion criteria: Complications such as severe headache, nausea and vomiting, severe digestive problems; Irregular consumption Tablets (Two consecutive meals or two servings of total); Alzheimer's and other mental disorders; drug abuse, alcohol and psychotropic drugs; trauma or stroke; a history of sensitivity to herbal medicines; Hearing and vision problems that interfere with the elderly.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 3
The Effect of Boswellia Serrata Extract on OsteoarthritisOsteoarthritis of kneeIRCT20190107042264N1Ahvaz University of Medical Sciences60
Completed
Phase 2
Investigating the effect of Boswellia Serrata, a kind of herbal remedy on cognitive impairments following closed head injuriesDiffuse axonal Injury.Traumatic compression of brain NOSIRCT138804082093N1Vice Chancellery for Research, Isfahan University of Medical Sciences40
Recruiting
Not Applicable
Evaluation of the effect of Boswellia serrata Roxb. ex Colebr. oleogum resin on sperm motility in men with sperm motility defects (asthenospermia)Asthenospermia.R86.9asthenospermiaIRCT20140817018828N7Yazd University of Medical Sciences50
Not yet recruiting
Phase 3
The efficacy of adding Boswellia serrataSchizophrenia.SchizophreniaIRCT20101130005280N48Mashhad University of Medical Sciences40
Completed
Not Applicable
Evaluation the efficasy of Boswellia serrata on patients with mild to moderate Alzheimer diseasepatients with mild to moderate Alzheimer.Alzheimer disease, unspecifiedIRCT2015051822306N1Shiraz University of Medical Sciences